The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
Aging leads to several geriatric conditions including osteoporosis (OP) and associated frailty syndrome. Treatments for these conditions are limited and none target fundamental drivers of pathology, and thus identifying strategies to delay progressive loss of tissue homeostasis and functional reserv...
Main Authors: | William S. Hambright, Xiaodong Mu, Xueqin Gao, Ping Guo, Yohei Kawakami, John Mitchell, Michael Mullen, Anna-Laura Nelson, Chelsea Bahney, Haruki Nishimura, Justin Hellwinkel, Andrew Eck, Johnny Huard |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.1155/2023/5572754 |
Similar Items
-
Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model
by: Rui Zhao, et al.
Published: (2023-12-01) -
Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep
by: Charles A. Huard, et al.
Published: (2023-08-01) -
Sustained-release losartan from peptide nanofibers promotes chondrogenesis
by: Kohei Yamaura, et al.
Published: (2023-02-01) -
The structural basis of ZMPSTE24-dependent laminopathies
by: Quigley, A, et al.
Published: (2013) -
The structural basis of ZMPSTE24-dependent laminopathies.
by: Quigley, A, et al.
Published: (2013)